Yes, it looks like today’s news is going to open up an entirely different market for CANB
Just like last week’s news about Pure Leaf Oil
So now CANB is operating in 3 different markets — medical CBD, consumer CBD and medical device CBD, which is going to be an enormous market
When I picked CANB, I did so because of their business model of physicians selling medical grade CBD Oil products to patients — that being CANB’s core market separated them from every other publicly traded CBD Oil company
With Pure Leaf Oil as their new line of consumer CBD products available at retail stores, now like CVSI and CWBHF, they are set to sell their products in the biggest and most established market
And with the 3rd subsidiary announced today — DuraMed — they are targeting the medical device market, which is a brand new category with huge room for growth — with their connection to HudiLab and Mobius Therapy, which is the use of CBD-infused pads with TENS units, CANB has now added a 3rd revenue stream, but just as importantly, a 2nd differentiator
CANB = CVSI/CWBHF + Medical CBD + Medical device CBD
That is certainly going to be a winning formula for CANB in 2019
News 
Market Data 
Discover 
